NEUROPACE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NEUROPACE, INC. (NPCE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-03
- NEUROPACE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $7.50M, a 27.12% increase from fiscal 2024.
- NEUROPACE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $5.90M, a 21.33% decline from fiscal 2023.
- NEUROPACE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $7.50M, a 41.41% decline from fiscal 2022.
- NEUROPACE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $12.80M, a 64.10% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $7.50M 10-K · filed 2026-03-03 |
| 2024-12-31 | $5.90M 10-K · filed 2026-03-03 |
| 2023-12-31 | $7.50M 10-K · filed 2025-03-04 |
| 2022-12-31 | $12.80M 10-K · filed 2024-03-05 |
| 2021-12-31 | $7.80M 10-K · filed 2023-03-02 |
| 2020-12-31 | $5.30M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |